Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07506616 · ClinicalTrials.gov registry record · Phase 1
Membrane Potential Mapping with18F-TPP
A Phase 1 study, sponsored by Yale University.
- Not yet
- Registry status
- Phase 1
- Development phase
- 24
- Enrollment target
NCT07506616 is a Phase 1 study that has not yet begun recruiting, run by Yale University. The registered enrollment target is 24 participants.
The verdict
NCT07506616, a Phase 1 study, has not yet begun recruiting, sponsored by Yale University.
- NOT YET RECRUITING
- Registry status
- Phase 1
- Development phase
- 24 participants
- Enrollment target
Study Summary
In this study, investigators propose to use PET imaging to study the pharmacokinetics of 18F-TPP and develop methods for imaging membrane potential (ΔΨT) in humans.
Interventions
- DRUG 18F-TPP
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2026-06 |
| Est. Completion | 2033-08 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07506616
The ClinicalTrials.gov registry entry for NCT07506616 describes a study currently listed as not yet recruiting, categorized as Phase 1. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which 18F-TPP is the first listed.
NCT07506616 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07506616 about?
NCT07506616 is a clinical study titled "Membrane Potential Mapping with18F-TPP". In this study, investigators propose to use PET imaging to study the pharmacokinetics of 18F-TPP and develop methods for imaging membrane potential (ΔΨT) in humans.
What is the current status of trial NCT07506616?
This trial is currently not yet recruiting. It is a Phase 1 study. The enrollment target is 24 participants. The study started on 2026-06. Estimated completion is 2033-08.
What interventions are being tested in trial NCT07506616?
The interventions under investigation include: 18F-TPP (DRUG).
Who is sponsoring clinical trial NCT07506616?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.